Universidade de Santo Amaro Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT00969254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Universidade de Santo Amaro (UNISA)

Active Ingredients

Drugs in Phase 3 Trials (2)

aloinium (1 trial)

phenazopyridine (gantanol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dysuria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2